nimodipine

FDA Drug Profile — Nymalize, nimodipine

nimodipine is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Nymalize, nimodipine. Available dosage forms: solution, capsule, liquid filled.

Drug Details

Generic Name
nimodipine
Brand Names
Nymalize, nimodipine
Application Number
NDA203340
Sponsor
Azurity Pharmaceuticals, Inc.
NDC Codes
3
Dosage Forms
SOLUTION, CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients
NIMODIPINE

Indications and Usage

1 INDICATIONS AND USE Nimodipine oral solution is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V). Nimodipine oral solution is a dihydropyridine calcium channel blocker indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I to V). (1)